Condition: Heart Failure · Systemic Inflammation · Sponsor: Novo Nordisk A/S
The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (inactive substance that looks like the study medicine but does not contain any medicine). The treatment participants get is decided by chance. Participant's chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study is expected to last for up to 1 year and 4 months.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Advanced Cardiovascular, LLC | Alexander City, Alabama, United States | Completed |
| Eastern Shore Rsrch Inst, LLC | Fairhope, Alabama, United States | Active Not Recruiting |
| Cardiology & Medicine Clinic | Little Rock, Arkansas, United States | Completed |
| Valley Clinical Trials, Inc. | Northridge, California, United States | Active Not Recruiting |
| Valley Clinical Trials, Inc. | Northridge, California, United States | Recruiting |
| UCI Health | Orange, California, United States | Completed |
| South California Heart Spc | Pasadena, California, United States | Active Not Recruiting |
| Clearwater Cardiovascular Consultants | Largo, Florida, United States | Completed |
| Clearwater Cardiovascular Consultants | Largo, Florida, United States | Recruiting |
| Ocala Cardiovascular Research | Ocala, Florida, United States | Active Not Recruiting |
| Ormond Beach Clinical Research | Ormond Beach, Florida, United States | Active Not Recruiting |
| St Johns Ctr Clin Rsch-St. Aug | Saint Augustine, Florida, United States | Active Not Recruiting |
+ 228 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06200207